Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Toldo

Showing results (81-90 of 136) with videos related to

Pageof 14
Sort By:
Biorxiv : the Preprint Server for Biology|March 31, 2025
UNCONVENTIONAL INTERLEUKIN-1 SIGNALING IN CARDIAC DYSFUNCTIONStefano Toldo, Pratyush Narayan, Eleonora Mezzaroma, et al.
Journal of Cardiovascular Pharmacology|March 8, 2017
Reduction of Myocardial Ischemia-Reperfusion Injury by Inhibiting Interleukin-1 AlphaAdolfo G Mauro, Eleonora Mezzaroma, Juan Torrado, et al.
Journal of Cardiovascular Pharmacology|April 11, 2018
Inhibiting the Inflammatory Injury After Myocardial Ischemia Reperfusion With Plasma-Derived Alpha-1 Antitrypsin: A Post Hoc Analysis of the VCU-α1RT StudyNayef Antar Abouzaki, Sanah Christopher, Cory Trankle, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Novel Pathophysiological, Diagnostic and Therapeutic Concepts in Acute and Recurrent PericarditisAldo Bonaventura, Georgia K Thomas, Michele Golino, et al.
Journal of Cardiovascular Pharmacology|February 13, 2019
The NLRP3 Inflammasome Inhibitor, OLT1177 (Dapansutrile), Reduces Infarct Size and Preserves Contractile Function After Ischemia Reperfusion Injury in the MouseStefano Toldo, Adolfo Gabriele Mauro, Zachary Cutter, et al.
Cardiovascular Drugs and Therapy|April 25, 2012
Recombinant human interleukin-1 receptor antagonist provides cardioprotection during myocardial ischemia reperfusion in the mouseStefano Toldo, Aaron M Schatz, Eleonora Mezzaroma, et al.
European Journal of Heart Failure|March 26, 2010
Interleukin-1beta modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouseAntonio Abbate, Benjamin W Van Tassell, Ignacio M Seropian, et al.
International Journal of Cardiology|February 25, 2024
Innate and adaptive immunity in acute myocarditisMichele Golino, Daniel Harding, Marco Giuseppe Del Buono, et al.
International Journal of Cardiology|February 21, 2016
Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia-reperfusion in the mouseStefano Toldo, Carlo Marchetti, Adolfo G Mauro, et al.
Journal of Cardiovascular Pharmacology|December 17, 2013
A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouseCarlo Marchetti, Jeremy Chojnacki, Stefano Toldo, et al.
Pageof 14

Showing results (81-90 of 136) with videos related to

Sort By:
Pageof 14
Biorxiv : the Preprint Server for Biology|March 31, 2025
UNCONVENTIONAL INTERLEUKIN-1 SIGNALING IN CARDIAC DYSFUNCTIONStefano Toldo, Pratyush Narayan, Eleonora Mezzaroma, et al.
Journal of Cardiovascular Pharmacology|March 8, 2017
Reduction of Myocardial Ischemia-Reperfusion Injury by Inhibiting Interleukin-1 AlphaAdolfo G Mauro, Eleonora Mezzaroma, Juan Torrado, et al.
Journal of Cardiovascular Pharmacology|April 11, 2018
Inhibiting the Inflammatory Injury After Myocardial Ischemia Reperfusion With Plasma-Derived Alpha-1 Antitrypsin: A Post Hoc Analysis of the VCU-α1RT StudyNayef Antar Abouzaki, Sanah Christopher, Cory Trankle, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Novel Pathophysiological, Diagnostic and Therapeutic Concepts in Acute and Recurrent PericarditisAldo Bonaventura, Georgia K Thomas, Michele Golino, et al.
Journal of Cardiovascular Pharmacology|February 13, 2019
The NLRP3 Inflammasome Inhibitor, OLT1177 (Dapansutrile), Reduces Infarct Size and Preserves Contractile Function After Ischemia Reperfusion Injury in the MouseStefano Toldo, Adolfo Gabriele Mauro, Zachary Cutter, et al.
Cardiovascular Drugs and Therapy|April 25, 2012
Recombinant human interleukin-1 receptor antagonist provides cardioprotection during myocardial ischemia reperfusion in the mouseStefano Toldo, Aaron M Schatz, Eleonora Mezzaroma, et al.
European Journal of Heart Failure|March 26, 2010
Interleukin-1beta modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouseAntonio Abbate, Benjamin W Van Tassell, Ignacio M Seropian, et al.
International Journal of Cardiology|February 25, 2024
Innate and adaptive immunity in acute myocarditisMichele Golino, Daniel Harding, Marco Giuseppe Del Buono, et al.
International Journal of Cardiology|February 21, 2016
Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia-reperfusion in the mouseStefano Toldo, Carlo Marchetti, Adolfo G Mauro, et al.
Journal of Cardiovascular Pharmacology|December 17, 2013
A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouseCarlo Marchetti, Jeremy Chojnacki, Stefano Toldo, et al.
Pageof 14